| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.26 | 7e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.57 | 0.0002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.22 | 0.0004 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0005 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.0005 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |